{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:21:06Z","timestamp":1791058866911,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10096-025-05331-1","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:25:04Z","timestamp":1766492704000},"page":"955-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changing antimicrobial prescribing patterns, and laboratory reporting in Enterococcus faecalis infective endocarditis at a tertiary Australian centre"],"prefix":"10.1007","volume":"45","author":[{"given":"Nilanthy","family":"Vigneswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra Y. L.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony M.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"2","key":"5331_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2019.04.059","volume":"74","author":"A Dahl","year":"2019","unstructured":"Dahl A, Iversen K, Tonder N, Hoest N, Arpi M, Dalsgaard M et al (2019) Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol 74(2):193\u2013201","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5331_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040704","volume":"12","author":"L Herrera-Hidalgo","year":"2023","unstructured":"Herrera-Hidalgo L, Fern\u00e1ndez-Rubio B, Luque-M\u00e1rquez R, L\u00f3pez-Cort\u00e9s LE, Gil-Navarro MV, De Alarc\u00f3n A (2023) Treatment of Enterococcus faecalis infective endocarditis: a continuing challenge. Antibiotics 12(4):704","journal-title":"Antibiotics"},{"issue":"2","key":"5331_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cid\/ciac777","volume":"76","author":"VG Fowler","year":"2023","unstructured":"Fowler VG, Durack DT, Selton-Suty C, Athan E, Bayer AS, Chamis AL et al (2023) The 2023 Duke-ISCVID criteria for infective endocarditis. Clin Infect Dis 76(2):281\u2013290","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5331_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00843-21","volume":"60","author":"A Khan","year":"2022","unstructured":"Khan A, Miller WR, Axell-House D, Munita JM, Arias CA (2022) Antimicrobial susceptibility testing for enterococci. J Clin Microbiol 60(9):e00843\u2013e00821","journal-title":"J Clin Microbiol"},{"issue":"11","key":"5331_CR5","doi-asserted-by":"publisher","first-page":"O1075","DOI":"10.1111\/1469-0691.12756","volume":"20","author":"JM Pericas","year":"2014","unstructured":"Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK et al (2013) Enterococcus faecalis infective endocarditis: pilot study of gentamicin duration and outcome. Circulation 127(17):1810\u20131817","journal-title":"Clin Microbiol Infect"},{"key":"5331_CR6","doi-asserted-by":"publisher","unstructured":"Connor P, Sorin M, Katergi K, Khalaf R, Fogarty C, Turenne M et al (2024) Revisiting adjunctive therapy for Enterococcus faecalis infective endocarditis: systematic review and meta-analysis. Clin Infect Dis ciae379. https:\/\/doi.org\/10.1093\/cid\/ciae379","DOI":"10.1093\/cid\/ciae379"},{"issue":"5","key":"5331_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jinf.2018.06.013","volume":"77","author":"A El Rafei","year":"2018","unstructured":"El Rafei A, DeSimone DC, Narichania AD, Sohail MR, Vikram HR, Li Z et al (2018) Dual \u03b2-lactam vs penicillin\u2013aminoglycoside therapy in Enterococcus faecalis infective endocarditis. J Infect 77(5):398\u2013404","journal-title":"J Infect"},{"issue":"3","key":"5331_CR8","doi-asserted-by":"publisher","first-page":"106522","DOI":"10.1016\/j.ijantimicag.2022.106522","volume":"59","author":"L Freeman","year":"2022","unstructured":"Freeman L, Milkovits A, McDaniel L, Everson N (2022) Penicillin\u2013gentamicin vs dual \u03b2-lactam in Enterococcus faecalis infective endocarditis. Int J Antimicrob Agents 59(3):106522","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5331_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jcm11010007","volume":"11","author":"L Herrera-Hidalgo","year":"2021","unstructured":"Herrera-Hidalgo L, Lomas-Cabezas JM, L\u00f3pez-Cort\u00e9s LE, Luque-M\u00e1rquez R, L\u00f3pez-Cort\u00e9s LF et al (2021) Ampicillin plus ceftriaxone for Enterococcus faecalis infective endocarditis in OPAT. J Clin Med 11(1):7","journal-title":"J Clin Med"},{"issue":"1","key":"5331_CR10","first-page":"e010128","volume":"65","author":"L Herrera-Hidalgo","year":"2021","unstructured":"Herrera-Hidalgo L, de Alarc\u00f3n A, L\u00f3pez-Cort\u00e9s LE, Luque-M\u00e1rquez R, L\u00f3pez-Cort\u00e9s LF et al (2021) Once-daily high-dose ceftriaxone plus ampicillin in OPAT. Antimicrob Agents Chemother 65(1):e010128","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5331_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae168","volume":"6","author":"S Briggs","year":"2024","unstructured":"Briggs S, Duffy E, Bhally H, Broom M, Campbell P, Lane R et al (2024) Outpatient parenteral antimicrobial therapy for patients with Enterococcus faecalis endocarditis using continuous infusion IV benzylpenicillin plus IV ceftriaxone. JAC-Antimicrobial Resistance 6(5):dlae168. https:\/\/doi.org\/10.1093\/jacamr\/dlae168","journal-title":"JAC-Antimicrobial Resistance"},{"issue":"3","key":"5331_CR12","doi-asserted-by":"publisher","first-page":"dlab128","DOI":"10.1093\/jacamr\/dlab128","volume":"3","author":"PR Ingram","year":"2021","unstructured":"Ingram PR, Ng J, Mathieson C, Mowlaboccus S, Coombs G, Raby E et al (2021) Outpatient parenteral antimicrobial therapy with benzylpenicillin plus ceftriaxone for enterococcal endovascular infection. JAC Antimicrob Resist 3(3):dlab128","journal-title":"JAC Antimicrob Resist"},{"issue":"10","key":"5331_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9102150","volume":"9","author":"L Thieme","year":"2021","unstructured":"Thieme L, Briggs S, Duffy E, Makarewicz O, Pletz MW (2021) In vitro synergism of penicillin plus ceftriaxone against Enterococcus faecalis. Microorganisms 9(10):2150","journal-title":"Microorganisms"},{"issue":"4","key":"5331_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00621-22","volume":"10","author":"JA Cusumano","year":"2022","unstructured":"Cusumano JA, Khan R, Shah Z, Philogene C, Harrichand A, Huang V (2022) Penicillin vs ampicillin plus ceftriaxone synergy against Enterococcus faecalis. Microbiol Spectr 10(4):e00621\u2013e00622","journal-title":"Microbiol Spectr"},{"issue":"6","key":"5331_CR15","doi-asserted-by":"publisher","first-page":"dlae167","DOI":"10.1093\/jacamr\/dlae167","volume":"6","author":"YH Do Rego","year":"2024","unstructured":"Do Rego YH, Kherabi Y, Corvec S, Plouzeau-Jayle C, Bouchiat C, Macheda G et al (2024) Outcomes of Enterococcus faecalis infective endocarditis according to amoxicillin MIC. JAC Antimicrob Resist 6(6):dlae167. https:\/\/doi.org\/10.1093\/jacamr\/dlae167","journal-title":"JAC Antimicrob Resist"},{"issue":"6","key":"5331_CR16","first-page":"e00291","volume":"63","author":"D Kim","year":"2019","unstructured":"Kim D, Lee H, Yoon E-J, Hong JS, Shin JH, Uh Y et al (2019) Ampicillin-susceptible but penicillin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 63(6):e00291\u2013e00219","journal-title":"Antimicrob Agents Chemother"},{"key":"5331_CR17","doi-asserted-by":"crossref","unstructured":"Infante VHP, Concei\u00e7\u00e3o N, de Oliveira AG, da, Costa Darini AL (2016) pbp4 polymorphisms in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis. FEMS Microbiol Lett. 363(7):fnw044","DOI":"10.1093\/femsle\/fnw044"},{"issue":"4","key":"5331_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1373\/jalm.2018.027821","volume":"3","author":"TH Lines","year":"2019","unstructured":"Lines TH, Greene MH, Nesbitt WJ, Stratton CW, Schmitz JE (2019) Enterococcus faecalis and penicillin susceptibility testing: challenges. J Appl Lab Med 3(4):730\u2013732","journal-title":"J Appl Lab Med"},{"issue":"6","key":"5331_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/PAT.0000000000000146","volume":"46","author":"YE Tan","year":"2014","unstructured":"Tan YE, Ng LS, Tan TY (2014) Evaluation of PRASEF phenotype by Vitek-2. Pathology 46(6):544\u2013550","journal-title":"Pathology"},{"key":"5331_CR20","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2023","unstructured":"Clinical and Laboratory Standards Institute (2023) Performance standards for antimicrobial susceptibility testing, 33rd edn. CLSI, Wayne, PA","edition":"33"},{"key":"5331_CR21","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2025) Breakpoint tables for interpretation of mics and zone diameters. Version 15.0. pp 40\u201344"},{"issue":"2","key":"5331_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1071\/MA24018","volume":"45","author":"GW Coombs","year":"2024","unstructured":"Coombs GW, Daley DA, Bell JM, Mowlaboccus S, Iredell JR (2024) The Australian group on antimicrobial resistance. Microbiol Aust 45(2):23","journal-title":"Microbiol Aust"},{"issue":"11","key":"5331_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"ME Charlson","year":"1994","unstructured":"Charlson ME, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245\u20131251","journal-title":"J Clin Epidemiol"},{"issue":"17","key":"5331_CR24","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","volume":"127","author":"A Dahl","year":"2013","unstructured":"Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK et al (2013) Enterococcus faecalis infective endocarditis: pilot study of gentamicin duration and outcome. Circulation 127(17):1810\u20131817","journal-title":"Circulation"},{"issue":"39","key":"5331_CR25","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S et al (2023) 2023 ESC guidelines for the management of endocarditis. Eur Heart J 44(39):3948\u20133962. https:\/\/doi.org\/10.1093\/eurheartj\/ehad193","journal-title":"Eur Heart J"},{"issue":"2","key":"5331_CR26","doi-asserted-by":"publisher","first-page":"e0164622","DOI":"10.1128\/spectrum1646-22","volume":"11","author":"H Wu","year":"2023","unstructured":"Wu H, Lutgring JD, McDonald LC, Webb A, Fields V, Blum L et al (2023) Selective and cascade reporting of antimicrobial susceptibility testing results and its impact on antimicrobial resistance surveillance. Microbiol Spectr 11(2):e0164622. https:\/\/doi.org\/10.1128\/spectrum1646-22","journal-title":"Microbiol Spectr"},{"issue":"6","key":"5331_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.cmi.2019.03.007","volume":"25","author":"TP Cusack","year":"2019","unstructured":"Cusack TP et al (2019) Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance. Clin Microbiol Infect 25(6):782\u2013790. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.007","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"5331_CR28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jacc.2019.11.047","volume":"75","author":"JM Peric\u00e0s","year":"2020","unstructured":"Peric\u00e0s JM, Llopis J, Mu\u00f1oz P et al (2020) A contemporary picture of enterococcal endocarditis. J Am Coll Cardiol 75(5):482\u2013494. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.047","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5331_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/cid\/ciac777","volume":"76","author":"P Danneels","year":"2023","unstructured":"Danneels P, Hamel JF, Picard L, Rezig S, Martinet P, Lorleac\u2019h A et al (2023) Impact of Enterococcus faecalis endocarditis treatment on risk of relapse. Clin Infect Dis 76(2):281\u2013290","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5331_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae033","volume":"6","author":"N Garofoli","year":"2024","unstructured":"Garofoli N, Joly V, Le Pluart D, Hobson CA, Beaumont AL, Lariven S et al (2024) Enterococcal endocarditis management and relapses. JAC-Antimicrobial Resistance 6(2):dlae033. https:\/\/doi.org\/10.1093\/jacamr\/dlae033","journal-title":"JAC-Antimicrobial Resistance"},{"issue":"5","key":"5331_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac096","volume":"4","author":"N Vigneswaran","year":"2022","unstructured":"Vigneswaran N, McKew G (2022) A retrospective study of Enterococcus faecalis infective endocarditis: comparison of clinical characteristics and outcomes associated with treatment. JAC-Antimicrobial Resistance 4(5):dlac096. https:\/\/doi.org\/10.1093\/jacamr\/dlac096","journal-title":"JAC-Antimicrobial Resistance"},{"issue":"17","key":"5331_CR32","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.113.002431","volume":"127","author":"JM Miro","year":"2013","unstructured":"Miro JM, Pericas JM, del Rio A, Hospital Clinic Endocarditis Study Group (2013) Ampicillin plus short-course gentamicin vs ampicillin plus ceftriaxone for Enterococcus faecalis endocarditis. Circulation 127(17):1763\u20131766","journal-title":"Circulation"},{"issue":"5","key":"5331_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1808312","volume":"380","author":"K Iversen","year":"2019","unstructured":"Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT et al (2019) Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med 380(5):415\u2013424. https:\/\/doi.org\/10.1056\/NEJMoa1808312","journal-title":"N Engl J Med"},{"issue":"3","key":"5331_CR34","doi-asserted-by":"publisher","first-page":"106918","DOI":"10.1016\/j.ijantimicag.2023.106918","volume":"62","author":"C Hidalgo-Tenorio","year":"2023","unstructured":"Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enr\u00edquez-G\u00f3mez A, Mu\u00f1oz P, Plata-Ciezar A, Mir\u00f3 JM et al (2023) EN-DALBACEN study group. EN-DALBACEN 2 cohort: real-life study of Dalbavancin as sequential\/consolidation therapy in patients with infective endocarditis due to Gram-positive Cocci. Int J Antimicrob Agents 62(3):106918","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"5331_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab099","volume":"3","author":"A Guleri","year":"2021","unstructured":"Guleri A, More R, Sharma R, Wong M, Abdelrahman A (2021) Use of dalbavancin in infective endocarditis: a case series. JAC-Antimicrobial Resistance 3(3):dlab099. https:\/\/doi.org\/10.1093\/jacamr\/dlab099","journal-title":"JAC-Antimicrobial Resistance"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05331-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:34:06Z","timestamp":1776350046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05331-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5331"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05331-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}